Developer docs
API playgroundTry for free, no card

Search company profiles

Heunet Pharma

Full company profile

uuid02mapvz

Namestring
Heunet Pharma
Legal namestring
Heunet Pharma GmbH
Websiteurl
heunet.de
Company typeenum
Private
Founded yearstring
-
Short descriptiontext

Heunet Pharma GmbH is a Nuremberg-based, wholly owned subsidiary of India's Torrent Group that markets and distributes finished pharmaceutical products into the German healthcare market, including co-distributed Heumann Pharma generics, selling through German channel partners.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNuremberg, Germany
HQ citystring
Nuremberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, finished dosage forms, generic pharmaceuticals, co-distribution rights, German healthcare market
Industry4 codes
PRIMARYHLAIAJAA
Full-Line Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAD
Oral Solid Dose (OSD) Generics
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
  • Wholesale Trade Agents and Brokers4251
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceuticals (finished dosage forms) — marketing and distribution
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Marketing and distribution of finished pharmaceutical products (finished drugs)
TypeTransaction Fee
Description

Heunet Pharma earns revenue by marketing and selling finished pharmaceutical products (Fertigarzneimittel) to the German healthcare market. Revenue is product-transaction based, with margins tied to the purchase and resale economics of the medicines marketed, rather than recurring subscriptions or usage-based billing.

heunet.de
2Co-distribution of Heumann Pharma products
TypeTransaction Fee
Description

Heunet holds co-distribution rights (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, generating distribution-based revenue on branded and generic pharmaceutical products marketed into the German market.

heunet.de
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Supply Chain, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Heunet Pharma GmbH markets and sells finished pharmaceutical products (Fertigarzneimittel) for the German healthcare market. Its portfolio is supplied through its 100% parent, the Torrent Group (Ahmedabad, India), which the company states allows it to offer high-quality medicines on time and at favorable prices. Alongside its own range, it holds a co-distribution right (Mitvertriebsrecht) for the product portfolio of Heumann Pharma GmbH & Co. Generica KG, extending the generics offered into the German market.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Heunet Pharma Finished Pharmaceutical Portfolio (Fertigarzneimittel)
CategoryPharmaceutical products — finished dosage forms
Description

Heunet Pharma GmbH markets and sells numerous finished pharmaceuticals (finished dosage forms) for the German healthcare market, supplied and quality-assured through its 100% parent company, the Torrent Group (Ahmedabad, India), which the company states enables timely and competitively priced supply. The portfolio is supported by professional product information such as specialist information (Fachinformationen) and training materials, and trade terms are governed by published general terms and conditions (AGB).

2Heumann Pharma Co-Distribution Range
CategoryPharmaceutical products — co-distributed generics
Description

Heunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, extending its marketed portfolio with generics from the Heumann range for the German market. Detailed product information, including specialist information and training material where applicable, is published on heumann.de.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Torrent Group (Torrent Pharma)
Strategic tierFlagship / Parent Company — Sole OwnerTypeStrategic or Co-development Partner
Description

Heunet Pharma GmbH is a 100 percent subsidiary of the Torrent Group, a globally operating pharmaceutical corporation headquartered in Ahmedabad, India. This strong connection is stated to enable Heunet Pharma to offer high-quality medicines in a timely manner and at favorable prices. Further information about the Torrent Group is available at www.torrentpharma.com.

heunet.de
2Heumann Pharma GmbH & Co. Generica KG
Strategic tierCore — Co-Distribution Portfolio RightsTypeChannel Partner/ Reseller/ Distributor
Description

Heunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG. Detailed product information such as specialist information and, where applicable, training materials can be found at www.heumann.de.

heunet.de
Peers10 records
1Heumann Pharma GmbH & Co. Generica KG
TypeDirect peer
Description

German generics manufacturer whose product portfolio Heunet co-distributes (Mitvertriebsrecht) into the German healthcare market. It is the most directly comparable company: same German market, same generic-led finished-medicine portfolio, and an established German marketing and distribution footprint.

2ratiopharm
TypeDirect peer
Description

German-focused generics company with a large German field sales force marketing and distributing finished medicines to pharmacies, doctors and the wholesale channel. It competes for the same channel partners and the same German prescriber and pharmacy wallet as Heunet.

3HRA Pharma
TypeDirect peer
Description

German specialty pharmaceutical marketing and distribution company that brings third-party products into the German market via its own sales force and regulatory/medical-information infrastructure. Structurally very close to Heunet's marketing-and-distribution-plus-co-promotion model, though focused on specialty indications.

4Acino
TypeDirect peer
Description

Pharmaceutical commercial services and distribution partner that provides marketing, supply-chain and access services for manufacturers in European markets including Germany. Comparable for its hybrid model of owning or co-owning country-level product rights and running local commercial operations.

5Accord Healthcare
TypeDirect peer
Description

Generics-focused pharmaceutical group with substantial German operations supplying finished medicines to pharmacies and hospitals. It competes on the same product-and-price axis in Germany that Heunet's value proposition relies on, but with far greater scale.

6Zentiva
TypeDirect peer
Description

European generics manufacturer and distributor with a leading German presence built around a national sales and logistics network. Comparable to Heunet in the generic finished-medicine model and German market exposure, though it also owns manufacturing assets.

7Sandoz
TypeBroad incumbent
Description

Large global generics and biosimilars company with a top-tier German business across branded generics, biosimilars and OTC brands. It sets the price and service benchmark that Heunet's 'competitively priced' positioning is measured against, without sharing Heunet's focused, single-market distribution-only model.

8STADA Arzneimittel AG
TypeBroad incumbent
Description

German-headquartered branded and generic pharmaceutical group with deep German retail, pharmacy and wholesaler relationships. It is the incumbent whose scale and portfolio breadth define the competitive set Heunet sells into.

9Teva Pharmaceutical Industries
TypeBroad incumbent
Description

Global generics leader with one of the largest German generic footprints, competing directly for German tender and pharmacy volume. Relevant as the primary source of price and volume pressure on mid-sized generic marketing partners like Heunet.

10Recordati
TypeBroad incumbent
Description

European specialty pharmaceutical group with an active German business marketing branded and specialty medicines through dedicated German commercial operations. It illustrates the scaled, portfolio-owning end of the spectrum in which Heunet operates as a distributor-marketer.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Heunet Pharma

Pharmaceuticals (finished dosage forms) — marketing and distributionheunet.de

Heunet Pharma GmbH is a Nuremberg-based, wholly owned subsidiary of India's Torrent Group that markets and distributes finished pharmaceutical products into the German healthcare market, including co-distributed Heumann Pharma generics, selling through German channel partners.

Heunet Pharma firmographics

Firmographics
Name
Heunet Pharma
Legal name
Heunet Pharma GmbH
Website
https://heunet.de
Company type
Private
Operating status
Operating
Short description
Heunet Pharma GmbH is a Nuremberg-based, wholly owned subsidiary of India's Torrent Group that markets and distributes finished pharmaceutical products into the German healthcare market, including co-distributed Heumann Pharma generics, selling through German channel partners.
Ownership category
akta.pro rank

Heunet Pharma industry classification

Industry
Product category
Pharmaceuticals (finished dosage forms) — marketing and distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (4242), Wholesale Trade Agents and Brokers (4251)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAA
Full-Line Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAD
Oral Solid Dose (OSD) Generics

Keywords

  • Pharmaceutical distribution
  • Finished dosage forms
  • Generic pharmaceuticals
  • Co-distribution rights
  • German healthcare market

Where Heunet Pharma is headquartered

Location

Headquarters

HQ city
Nuremberg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Heunet Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations

Revenue model

  1. Marketing and distribution of finished pharmaceutical products (finished drugs): Heunet Pharma earns revenue by marketing and selling finished pharmaceutical products (Fertigarzneimittel) to the German healthcare market. Revenue is product-transaction based, with margins tied to the purchase and resale economics of the medicines marketed, rather than recurring subscriptions or usage-based billing.
  2. Co-distribution of Heumann Pharma products: Heunet holds co-distribution rights (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, generating distribution-based revenue on branded and generic pharmaceutical products marketed into the German market.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Heunet Pharma product offering

Product offering

Core offering

Heunet Pharma GmbH markets and sells finished pharmaceutical products (Fertigarzneimittel) for the German healthcare market. Its portfolio is supplied through its 100% parent, the Torrent Group (Ahmedabad, India), which the company states allows it to offer high-quality medicines on time and at favorable prices. Alongside its own range, it holds a co-distribution right (Mitvertriebsrecht) for the product portfolio of Heumann Pharma GmbH & Co. Generica KG, extending the generics offered into the German market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Heunet Pharma Finished Pharmaceutical Portfolio (Fertigarzneimittel) Heunet Pharma GmbH markets and sells numerous finished pharmaceuticals (finished dosage forms) for the German healthcare market, supplied and quality-assured through its 100% parent company, the Torrent Group (Ahmedabad, India), which the company states enables timely and competitively priced supply. The portfolio is supported by professional product information such as specialist information (Fachinformationen) and training materials, and trade terms are governed by published general terms and conditions (AGB).
  • Heumann Pharma Co-Distribution Range Heunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, extending its marketed portfolio with generics from the Heumann range for the German market. Detailed product information, including specialist information and training material where applicable, is published on heumann.de.

Companies that use Heunet Pharma

Customer profile

Segments1 record

Ideal customer profiles1 record

Heunet Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Heunet Pharma partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship / parent company — sole owner and core — co-distribution portfolio rights.

  • Torrent Group (Torrent Pharma)flagship / parent company — sole ownerStrategic or Co-development PartnerHeunet Pharma GmbH is a 100 percent subsidiary of the Torrent Group, a globally operating pharmaceutical corporation headquartered in Ahmedabad, India. This strong connection is stated to enable Heunet Pharma to offer high-quality medicines in a timely manner and at favorable prices. Further information about the Torrent Group is available at www.torrentpharma.com.
  • Heumann Pharma GmbH & Co. Generica KGcore — co-distribution portfolio rightsChannel Partner/ Reseller/ DistributorHeunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG. Detailed product information such as specialist information and, where applicable, training materials can be found at www.heumann.de.

Scale indicators3 records

Heunet Pharma competitors and assessment

Company assessment

Direct peers

  • Heumann Pharma GmbH & Co. Generica KG: German generics manufacturer whose product portfolio Heunet co-distributes (Mitvertriebsrecht) into the German healthcare market. It is the most directly comparable company: same German market, same generic-led finished-medicine portfolio, and an established German marketing and distribution footprint.
  • ratiopharm: German-focused generics company with a large German field sales force marketing and distributing finished medicines to pharmacies, doctors and the wholesale channel. It competes for the same channel partners and the same German prescriber and pharmacy wallet as Heunet.
  • HRA Pharma: German specialty pharmaceutical marketing and distribution company that brings third-party products into the German market via its own sales force and regulatory/medical-information infrastructure. Structurally very close to Heunet's marketing-and-distribution-plus-co-promotion model, though focused on specialty indications.
  • Acino: Pharmaceutical commercial services and distribution partner that provides marketing, supply-chain and access services for manufacturers in European markets including Germany. Comparable for its hybrid model of owning or co-owning country-level product rights and running local commercial operations.
  • Accord Healthcare: Generics-focused pharmaceutical group with substantial German operations supplying finished medicines to pharmacies and hospitals. It competes on the same product-and-price axis in Germany that Heunet's value proposition relies on, but with far greater scale.
  • Zentiva: European generics manufacturer and distributor with a leading German presence built around a national sales and logistics network. Comparable to Heunet in the generic finished-medicine model and German market exposure, though it also owns manufacturing assets.

Broad incumbents

  • Sandoz: Large global generics and biosimilars company with a top-tier German business across branded generics, biosimilars and OTC brands. It sets the price and service benchmark that Heunet's 'competitively priced' positioning is measured against, without sharing Heunet's focused, single-market distribution-only model.
  • STADA Arzneimittel AG: German-headquartered branded and generic pharmaceutical group with deep German retail, pharmacy and wholesaler relationships. It is the incumbent whose scale and portfolio breadth define the competitive set Heunet sells into.
  • Teva Pharmaceutical Industries: Global generics leader with one of the largest German generic footprints, competing directly for German tender and pharmacy volume. Relevant as the primary source of price and volume pressure on mid-sized generic marketing partners like Heunet.
  • Recordati: European specialty pharmaceutical group with an active German business marketing branded and specialty medicines through dedicated German commercial operations. It illustrates the scaled, portfolio-owning end of the spectrum in which Heunet operates as a distributor-marketer.

Market position

Customer concentration

Heunet Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Heunet Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Heunet Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Heunet Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heunet Pharma

What does Heunet Pharma do?

Heunet Pharma GmbH markets and sells finished pharmaceutical products (Fertigarzneimittel) for the German healthcare market. Its portfolio is supplied through its 100% parent, the Torrent Group (Ahmedabad, India), which the company states allows it to offer high-quality medicines on time and at favorable prices. Alongside its own range, it holds a co-distribution right (Mitvertriebsrecht) for the product portfolio of Heumann Pharma GmbH & Co. Generica KG, extending the generics offered into the German market.

Is Heunet Pharma a public or private company?

Heunet Pharma is a private company. It is classified as corporate owned and is currently operating.

When was Heunet Pharma founded?

Heunet Pharma was founded in -1.

Where is Heunet Pharma based?

Heunet Pharma is headquartered in Nuremberg, Germany, in the Europe region.

How does Heunet Pharma make money?

Two revenue lines are on record. Marketing and distribution of finished pharmaceutical products (finished drugs) is the primary driver. The others are co-distribution of Heumann Pharma products.

Who are Heunet Pharma's main competitors?

Direct peers on record are Heumann Pharma GmbH & Co. Generica KG, ratiopharm, HRA Pharma, Acino, Accord Healthcare and Zentiva. Broad incumbents are Sandoz, STADA Arzneimittel AG, Teva Pharmaceutical Industries and Recordati.

Does Heunet Pharma have an API?

No public API is recorded for Heunet Pharma.

What industry is Heunet Pharma in?

Heunet Pharma's product category is Pharmaceuticals (finished dosage forms) — marketing and distribution. Its primary akta.pro industry code is HLAIAJAA, Full-Line Pharmaceutical Wholesalers, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 4242 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales